Patch test-proven delayed-type hypersensitivity from naltrexone/bupropion possibly eliciting psoriasis

Contact Dermatitis. 2021 Oct;85(4):456-458. doi: 10.1111/cod.13875. Epub 2021 May 11.

Authors

Regina Caldas¹, Sara Campos-Lopes², Maria J Guimarães¹, Joana Areal³, Marta Alves², Teresa Pereira¹

Affiliations

¹ Department of Dermatology and Venereology, Hospital de Braga, Braga, Portugal.
² Department of Endocrinology, Hospital de Braga, Braga, Portugal.
³ Department of Surgical Pathology, Hospital de Braga, Braga, Portugal.

PMID: 33929728
DOI: 10.1111/cod.13875

No abstract available

Keywords: acute generalized exanthematous pustulosis; bupropion; case report; drug hypersensitivity; naltrexone/bupropion; patch test; psoriasis.

Publication types

Case Reports

MeSH terms

Acute Generalized Exanthematous Pustulosis / etiology
Anti-Obesity Agents / adverse effects
Bupropion / adverse effects*
Female
Humans
Hypersensitivity, Delayed / chemically induced*
Middle Aged
Naltrexone / adverse effects*
Patch Tests
Psoriasis / chemically induced*

Substances

Anti-Obesity Agents
Bupropion
Naltrexone